Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - OTHER CURRENT ASSETS
Other Current Assets DNLI - Denali Therapeutics Inc.
26.2 M
LAST VALUE
-7.46%
2 YEAR CAGR
26.81%
5 YEAR CAGR
0.00%
10 YEAR CAGR